MDA Celebrates Approval of New Treatment

Excerpt from PR Newswire (September 19, 2016): “The Muscular Dystrophy Association today celebrated news of the U.S. Food and Drug Administration’s decision to grant accelerated approval for eteplirsen, the first disease-modifying drug to treat the most common childhood form of muscular dystrophy. Accelerated approval of the drug, which will treat a subset of those living […]

MDA Unveils Revitalized Brand at Carnegie Hall

On January 29, 2016, MDA launched its revitalized brand at Carnegie Hall, a stage that has given voice and visibility to so many families affected by muscle-debilitating diseases over the years….